Wurz and Charette
oil (148 mg, 90%) in a 93:7 E:Z ratio. Separation of the
diastereomers is possible using a less polar eluent (3% EtOAc/
hexane).
an intuitively straightforward, yet novel synthesis of the
antidepressant (()-transcycloamine.40 Typically, the cy-
clopropyl amine is prepared via a Curtius rearrangement
from the corresponding acid and often results in low
isolated yields.41 Reductions involving nitrocyclopropanes
17b and 17c also proceed with similar efficiencies,
affording >60% yield for the two-step sequence.
Gen er a l P r oced u r e for th e in Situ Rh od iu m (II) Ca r -
boxyla te-Ca ta lyzed Cyclop r op a n a tion s of Alk en es w ith
r-Nitr oester s a n d P h I(OAc)2 (Ta ble 1). Styrene (587 mg,
0.65 mL, 5 equiv) was added to a 25 mL round-bottomed flask
containing the required amount of [Rh(OPiv)2]2 catalyst (3.4
mg, 5.6 × 10-3 mmol, 0.5 mol %) and ethyl nitroacetate (150
mg, 1.13 mmol, 1 equiv). Iodobenzene diacetate (400 mg, 1.24
mmol, 1.1 equiv) was then added in one portion and the
mixture allowed to stir for 2 h open to air. The crude reaction
mixture was then chromatographed directly on silica gel, first
eluting with hexane (to remove excess alkene) and then with
5% EtOAc/hexane, affording 5a as a clear, colorless oil (223
mg, 84%) in a 92:8 E:Z ratio.
Gen er al Redu ction P r ocedu r e (Tables 3 an d 4). 2-Phen-
yl-1-nitrocyclopropane carboxylate ethyl ester (5a ) (104 mg,
0.44 mmol) was dissolved in 8.8 mL of i-PrOH (0.05 M) and
treated with 1 N HCl (4.4 mL, 10 equiv). Zinc dust (578 mg,
8.80 mmol, 20 equiv) was then added in small portions over
10-15 min and the solution allowed to stir for 2 h at room
temperature. The suspension was quenched by addition of a
saturated solution of NaHCO3 (15 mL), stirred for 15 min, and
filtered through a small plug of Celite, washing with EtOAc
(20 mL). The aqueous phase was further extracted with
dichloromethane (2 × 10 mL), the combined organic extracts
were dried over anhydrous MgSO4 and filtered, and the solvent
was removed under reduced pressure. The crude residue was
then chromatographed on silica gel pretreated with 1:5:19
Et3N/EtOAc/hexane, rinsed with 20% EtOAc/hexane, and
eluted with a 20-80% gradient of EtOAc/hexane. The E- and
Z-diastereomers were easily separated and the appropriate
fractions combined (ninhydrin used as a developer), affording
the corresponding amino esters 14a (70 mg, 77%).
Con clu sion s
In summary, the above methodology represents a rapid
and efficient method for the preparation and reduction
of a diverse series of aminocyclopropane carboxylates and
aromatic substituent containing aminocyclopropanes. It
represents an attractive method to access symmetric and
racemic substituted ACCs from commercially available
R-nitroesters and -olefins. Modest to high yields of
aminocyclopropane carboxylates can be obtained in short
reaction times. The asymmetric version of this reaction
proceeds with modest enantioselectivities, up to 72% ee,
and is still under examination.33 Furthermore, a variety
of methods exist for the resolution of cyclopropane amino
acids and can be applied to access the enantiomerically
enriched materials.42
Exp er im en ta l Section
See the Supporting Information for general synthetic meth-
ods and materials.
Nitr ocyclop r op a n e Ca r boxyla tes. Cyclopropanes 5a ,17a
5d ,18 5f,16a 5h ,18 5j,17a 5n ,33 9,16a and 17a ,38 have been previ-
ously reported. See the Supporting Information for the char-
acterization data (1H and 13C NMR spectra) of new nitro- and
aminocyclopropanes.
Da ta for (E)-Eth yl 1-Am in o-2-p h en yl-1-cyclop r op a n e-
ca r boxyla te ((E)-14a ): pale yellow oil; Rf 0.16 (60% EtOAc/
hexane); 1H NMR (400 MHz, CDCl3) δ 7.16-7.27 (m, 5H),
3.68-3.83 (m, 2H), 2.66 (t, J ) 8.7 Hz, 1H), 2.20 (s (br), 2H),
1.99 (dd, J ) 7.9, 5.0 Hz, 1H), 1.45 (dd, J ) 9.5, 5.0 Hz, 1H),
0.77 (t, J ) 7.1 Hz, 3H); 13C NMR (100 MHz, CDCl3) δ 173.7,
136.9, 129.4, 128.1, 126.7, 60.8, 43.2, 36.4, 20.0, 13.8; IR (film)
Ca u tion . Although we have not experienced any problems
in the handling of these compounds (trifluoromethanesulfonyl
azide and the R-nitro-R-diazocarbonyl derivatives), extreme care
should be taken when they are manipulated due to their
explosive nature.
3374 (NH), 1713 (CdO), 1144 cm-1
.
Gen er a l P r oced u r e for R h od iu m (II) Ca r b oxyla t e-
Ca ta lyzed Cyclop r op a n a tion s of Alk en es w ith r-Nitr o-
r-d ia zoester s (Ta bles 1 a n d 2). Styrene (145 mg, 0.16 mL,
2 equiv) was added to a 10 mL round-bottomed flask contain-
ing the required amount of [Rh(Octanoate)2]2 catalyst (2.7 mg,
3.5 × 10-3 mmol, 0.5 mol %). Ethyl nitrodiazoacetate (111 mg,
0.70 mmol, 1 equiv) was dissolved in anhydrous CH2Cl2 (0.70
mL, 1.0 M) and added slowly dropwise to the alkene/catalyst
solution, allowing for a controlled rate of N2 evolution (over
ca. 15-20 min). CH2Cl2 (0.5 mL) was then used to rinse the
flask containing the diazo to ensure complete transfer of
material. The reaction was allowed to stir for 2-4 h and then
concentrated under reduced pressure. The diastereoselectivity
of the cyclopropanation was determined by 1H NMR of the
crude reaction mixture. Purification by chromatography on
silica gel, first eluting with hexanes (to remove excess alkene)
and then 5% EtOAc/hexane, afforded 5a as a clear, colorless
Da ta for (Z)-Eth yl 1-Am in o-2-p h en yl-1-cyclop r op a n e-
ca r boxyla te ((Z)-14a ): pale yellow oil; Rf 0.57 (80% EtOAc/
hexane); 1H NMR (400 MHz, CDCl3) δ 7.28-7.35 (m, 2H),
7.23-7.27 (m, 3H), 4.22 (q, J ) 7.1 Hz, 2H), 2.82 (t, J ) 9.5
Hz, 1H), 1.84 (dd, J ) 9.6, 4.9 Hz, 1H), 1.56 (s (br), 2H), 1.44
(dd, J ) 7.6, 4.9 Hz, 1H), 1.31 (t, J ) 7.1 Hz, 3H); 13C NMR
(100 MHz, CDCl3) δ 175.6, 136.0, 129.4, 128.3, 127.0, 61.5,
41.3, 33.2, 22.1, 14.5; IR (film) 3384 (NH), 1717 (CdO), 1262,
1148, 834 cm-1; LRMS (APCI, Pos) m/z calcd for C12H15NO2
[M + H]+ 206.3, obsd 206.1.
“On e-P ot” Cyclop r op a n a tion Red u ction P r oced u r e
for th e P r ep a r a tion of Sen sitive Cyclop r op a n es 15a a n d
15b (Eq 2). [Rh(Octanoate)2]2 (4.5 mg, 0.5 mol %) was added
to a 100 mL round-bottomed flask, followed by 1,1-diphenyl-
ethene (415 mg, 2.30 mmol, 2 equiv). Methyl nitrodiazoacetate16a
(167 mg, 1.15 mmol, 1 equiv) was then added slowly dropwise
as a solution in CH2Cl2 (1.2 mL, 1.0 M) to the catalyst/alkene
mixture over 20 min. The solution was allowed to stir at room
temperature for 2 h, and then the CH2Cl2 was removed under
reduced pressure. The crude residue was dissolved in i-PrOH
(23 mL, 0.05 M) and treated with 1 N HCl (11.5 mL, 10 equiv).
Zinc dust (1.50 g, 23.0 mmol, 20 equiv) was added in small
portions over 10-15 min, and the resulting suspension was
allowed to stir for an additional 2 h. It was quenched by the
addition of a saturated solution of NaHCO3 (ca. 15 mL) and
allowed to stir for 15 min. The suspension was filtered through
a small Celite plug, washing with EtOAc (25 mL). After
separation of the organic phase, the aqueous phase was re-
extracted with CH2Cl2 (2 × 15 mL), and the combined organic
(40) A monoaminooxidase inhibitor (MAOI), tranylcypromine (Par-
nate, J atrosom N), which is an oral MAOI-type antidepressant, is used
to treat major depression in patients who have not responded to other
antidepressant therapies.
(41) (a) Shu, F.-C.; Zhou, Q.-L. Synth. Commun. 1999, 29, 567. (b)
Csuk, R.; Schabel, M. J .; Scholz, Y. v. Tetrahedron: Asymmetry 1996,
7, 3505. (c) Wang, M.-X.; Feng, G.-Q. Tetrahedron Lett. 2000, 41, 6501.
(42) (a) Wakamiya, T.; Oda, Y.; Fujita, H.; Shiba, T. Tetrahedron
Lett. 1986, 27, 2143. (b) Shiraishi, K.; Ichihara, A.; Sakamura, S. Agric.
Biol. Chem. 1977, 41, 2497. (c) Baldwin, J . E.; Adlington, R. M.;
Rawlings, B. J .; J ones, R. H. Tetrahedron Lett. 1985, 26 485. (d)
Kimura, H.; Stammer, C. H. J . Org. Chem. 1983, 46, 2440. (e) Kimura,
H.; Stammer, C. H.; Shimohigashi, Y.; Ren-Lin, C.; Stewart, J .
Biochem. Biophys. Res. Commun. 1983, 115, 112.
1268 J . Org. Chem., Vol. 69, No. 4, 2004